Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories, shared a post by Journal for ImmunoTherapy of Cancer on X, adding:
“DART is the gift that keeps on giving. Amazing insights into Immunotherapy and rare cancers. Oh, and I absolutely love NCI/SWOG.
This study opened at over 1000 sites. No one else can do that. Special Thanks to Sandip Patel and Young Kwang Chae for their leadership.”
Quoting Journal for ImmunoTherapy of Cancer‘s post:
“New JITC article:
Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609).”
Title: Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609)
Authors: Young Kwang Chae, Megan Othus, Jiyon Lyu, Seyoung Lee, Seungwon Paik, Eliana Dietrich, Chan Mi Jung, Liam Il-Young Chung, Sandip Patel, Razelle Kurzrock
Read The Full Article
Other articles about SWOG on OncoDaily.